Title | Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. |
Publication Type | Journal Article |
Year of Publication | 2015 |
Authors | Walz, AL, Ooms, A, Gadd, S, Gerhard, DS, Smith, MA, Auvil, JMGuidry, Meerzaman, D, Chen, Q-R, Hsu, CHao, Yan, C, Nguyen, C, Hu, Y, Bowlby, R, Brooks, D, Ma, Y, Mungall, AJ, Moore, RA, Schein, J, Marra, MA, Huff, V, Dome, JS, Chi, Y-Y, Mullighan, CG, Ma, J, Wheeler, DA, Hampton, OA, Jafari, N, Ross, N, Gastier-Foster, JM, Perlman, EJ |
Journal | Cancer Cell |
Volume | 27 |
Issue | 2 |
Pagination | 286-97 |
Date Published | 2015 Feb 09 |
ISSN | 1878-3686 |
Keywords | Gene Expression Regulation, Neoplastic, Homeodomain Proteins, Humans, Loss of Heterozygosity, MicroRNAs, Mutation, Neoplasm Recurrence, Local, Nerve Tissue Proteins, Polymorphism, Single Nucleotide, Ribonuclease III, RNA-Binding Proteins, Wilms Tumor |
Abstract | We report the most common single-nucleotide substitution/deletion mutations in favorable histology Wilms tumors (FHWTs) to occur within SIX1/2 (7% of 534 tumors) and microRNA processing genes (miRNAPGs) DGCR8 and DROSHA (15% of 534 tumors). Comprehensive analysis of 77 FHWTs indicates that tumors with SIX1/2 and/or miRNAPG mutations show a pre-induction metanephric mesenchyme gene expression pattern and are significantly associated with both perilobar nephrogenic rests and 11p15 imprinting aberrations. Significantly decreased expression of mature Let-7a and the miR-200 family (responsible for mesenchymal-to-epithelial transition) in miRNAPG mutant tumors is associated with an undifferentiated blastemal histology. The combination of SIX and miRNAPG mutations in the same tumor is associated with evidence of RAS activation and a higher rate of relapse and death. |
DOI | 10.1016/j.ccell.2015.01.003 |
Alternate Journal | Cancer Cell |
PubMed ID | 25670082 |
PubMed Central ID | PMC4800737 |
Grant List | T32 CA079447 / CA / NCI NIH HHS / United States U10CA98543 / CA / NCI NIH HHS / United States U24 CA114766 / CA / NCI NIH HHS / United States U10CA42326 / CA / NCI NIH HHS / United States HHSN261200800001C / CA / NCI NIH HHS / United States U01 CA088131 / CA / NCI NIH HHS / United States U10 CA098543 / CA / NCI NIH HHS / United States UO1CA88131 / CA / NCI NIH HHS / United States U10 CA180886 / CA / NCI NIH HHS / United States HHSN261200800001E / CA / NCI NIH HHS / United States U10 CA98543 / CA / NCI NIH HHS / United States |
Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors.
Similar Publications
DNA Methylation-Derived Immune Cell Proportions and Cancer Risk in Black Participants. Cancer Res Commun. 2024;4(10):2714-2723. | .
StratoMod: predicting sequencing and variant calling errors with interpretable machine learning. Commun Biol. 2024;7(1):1316. | .
Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk. BMC Med Genomics. 2024;17(1):255. | .